Company news
Alector, Inc. news in 2024
Alector, Inc.'s news releases, calls and decks from 2024, newest first.
Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update
November 24, 2024
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
November 13, 2024
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
November 5, 2024
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
September 18, 2024
Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
August 6, 2024
Alector to Host Mid-Year Earnings Conference Call
July 30, 2024
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
July 27, 2024
Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024
July 22, 2024
Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 19, 2024
Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform
June 9, 2024
Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 2, 2024
Alector Reports First Quarter 2024 Financial Results and Provides Business Update
May 7, 2024
Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 26, 2024
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
February 19, 2024
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
February 7, 2024
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
February 6, 2024
Alector Announces Closing of Public Offering
January 18, 2024
Alector Announces Pricing of Public Offering of Common Stock
January 16, 2024
Alector Announces Proposed Public Offering of Common Stock
January 15, 2024